A Retrospective Study of Outcome in Omalizumab Therapy in Chronic Urticaria, a Real Experience on 36 Kuwaiti Patients from a Single Tertiary Dermatology Center
Skin and Dermatological Research · 2022
DOI: 10.58489/3066-4942/001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin and Dermatological Research, 2022. Verfasst von Iman Almasry.
Abstract (Originalsprache)
Chronic urticaria (CU) is a common skin disease, characterized with wheals and itching, with or without angioedema. It is inflicting a substantial burden for patients, their family, and friends, the healthcare system, and society Chronic urticaria impacts -quality of life more than coronary artery disease or respiratory allergy. First line of the therapy are antihistamines. However, H1-antihistamine treatment leads to absence of symptoms in fewer than 50% of patients. Up-dosing of second-generation H1-antihistamines (up to fourfold) as recommended by the urticaria guideline, as second-line therapy can improve response; however, many cases do not respond to antihistamines and need a more effective approach Second line would be to increase the dose of antihistamines, above the licensed doses, is frequently required and still leaves a substantial proportion of patients symptomatic. Hence, short-term corticosteroid therapy (3–7 days) may be required. Unfortunately, for most unresponsive CU patients’ longer periods of corticosteroid therapy are needed and are associated with numerous undesired side effects.
Zitieren
APA
Almasry, I. (2022). A Retrospective Study of Outcome in Omalizumab Therapy in Chronic Urticaria, a Real Experience on 36 Kuwaiti Patients from a Single Tertiary Dermatology Center. Skin and Dermatological Research. https://doi.org/10.58489/3066-4942/001
Vancouver
Almasry I. A Retrospective Study of Outcome in Omalizumab Therapy in Chronic Urticaria, a Real Experience on 36 Kuwaiti Patients from a Single Tertiary Dermatology Center. Skin and Dermatological Research. 2022. doi:10.58489/3066-4942/001
BibTeX
@article{Almasry2022,
author = {Almasry, Iman},
title = {A Retrospective Study of Outcome in Omalizumab Therapy in Chronic Urticaria, a Real Experience on 36 Kuwaiti Patients from a Single Tertiary Dermatology Center},
journal = {Skin and Dermatological Research},
year = {2022},
doi = {10.58489/3066-4942/001}
}
EUVIMED